{"id":762,"date":"2026-03-11T10:11:18","date_gmt":"2026-03-11T09:11:18","guid":{"rendered":"https:\/\/www.novacos-law.com\/en\/?p=762"},"modified":"2026-03-11T10:22:50","modified_gmt":"2026-03-11T09:22:50","slug":"29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation","status":"publish","type":"post","link":"https:\/\/www.novacos-law.com\/en\/2026\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\/","title":{"rendered":"29. Marburger Gespr\u00e4che zum Pharmarecht (12. and 13. March 2026): Environmental protection and pharmaceutical law \/ 15 years of AMNOG \/ legal issues prior to marketing authorisation"},"content":{"rendered":"<div class=\"ms-outlook-mobile-reference-message skipProofing\">Our Senior Associate Patrick Findeisen will be speaking at the Marburger Gespr\u00e4che zum Pharmarecht, taking place on March 12 and 13, 2026 in Marburg.\u00a0In his presentation, Patrick will address the legal relevance of social and environmental criteria in rebate agreements in the pharmaceutical sector, with a particular focus on their growing importance to safeguard both the supply of medicinal products and the environment.<\/div>\n<div><\/div>\n<div class=\"ms-outlook-mobile-reference-message skipProofing\">More information about the event can be found <a href=\"https:\/\/www.novacos-law.com\/en\/wp-content\/uploads\/sites\/3\/2026\/03\/a4-flyer-gespraech-zum-pharmarecht_2026-digital-251216.pdf\">here<\/a>.<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Our Senior Associate Patrick Findeisen will be speaking at the Marburger Gespr\u00e4che zum Pharmarecht, taking place on March 12 and 13, 2026 in Marburg.\u00a0In his presentation, Patrick will address the legal relevance of social and environmental criteria in rebate agreements in the pharmaceutical sector, with a particular focus on their growing importance to safeguard both [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[6],"tags":[],"class_list":["post-762","post","type-post","status-publish","format-standard","hentry","category-events"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.9 - aioseo.com -->\n\t<meta name=\"description\" content=\"Our Senior Associate Patrick Findeisen will be speaking at the Marburger Gespr\u00e4che zum Pharmarecht, taking place on March 12 and 13, 2026 in Marburg. In his presentation, Patrick will address the legal relevance of social and environmental criteria in rebate agreements in the pharmaceutical sector, with a particular focus on their growing importance to safeguard both\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Irene Weigel\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.novacos-law.com\/en\/2026\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.9\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2026\\\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\\\/#article\",\"name\":\"29. Marburger Gespr\\u00e4che zum Pharmarecht (12. and 13. March 2026): Environmental protection and pharmaceutical law \\\/ 15 years of AMNOG \\\/ legal issues prior to marketing authorisation | NOVACOS\",\"headline\":\"29. Marburger Gespr\\u00e4che zum Pharmarecht (12. and 13. March 2026): Environmental protection and pharmaceutical law \\\/ 15 years of AMNOG \\\/ legal issues prior to marketing authorisation\",\"author\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/author\\\/irene\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/#organization\"},\"datePublished\":\"2026-03-11T10:11:18+01:00\",\"dateModified\":\"2026-03-11T10:22:50+01:00\",\"inLanguage\":\"en-GB\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2026\\\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2026\\\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\\\/#webpage\"},\"articleSection\":\"Events\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2026\\\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.novacos-law.com\\\/en\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/category\\\/events\\\/#listItem\",\"name\":\"Events\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/category\\\/events\\\/#listItem\",\"position\":2,\"name\":\"Events\",\"item\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/category\\\/events\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2026\\\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\\\/#listItem\",\"name\":\"29. Marburger Gespr\\u00e4che zum Pharmarecht (12. and 13. March 2026): Environmental protection and pharmaceutical law \\\/ 15 years of AMNOG \\\/ legal issues prior to marketing authorisation\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2026\\\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\\\/#listItem\",\"position\":3,\"name\":\"29. Marburger Gespr\\u00e4che zum Pharmarecht (12. and 13. March 2026): Environmental protection and pharmaceutical law \\\/ 15 years of AMNOG \\\/ legal issues prior to marketing authorisation\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/category\\\/events\\\/#listItem\",\"name\":\"Events\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/#organization\",\"name\":\"Novacos Law\",\"description\":\"Heil \\u2022 H\\u00fcbner \\u2022 Natz \\u2022 Oeben Partnerschaft mbB\",\"url\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/author\\\/irene\\\/#author\",\"url\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/author\\\/irene\\\/\",\"name\":\"Irene Weigel\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2026\\\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4b6e23b267feeae9cffc7e4f81dbd2efa7e19c1035301edf6a24a7beb9ae5ac9?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Irene Weigel\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2026\\\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\\\/#webpage\",\"url\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2026\\\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\\\/\",\"name\":\"29. Marburger Gespr\\u00e4che zum Pharmarecht (12. and 13. March 2026): Environmental protection and pharmaceutical law \\\/ 15 years of AMNOG \\\/ legal issues prior to marketing authorisation | NOVACOS\",\"description\":\"Our Senior Associate Patrick Findeisen will be speaking at the Marburger Gespr\\u00e4che zum Pharmarecht, taking place on March 12 and 13, 2026 in Marburg. In his presentation, Patrick will address the legal relevance of social and environmental criteria in rebate agreements in the pharmaceutical sector, with a particular focus on their growing importance to safeguard both\",\"inLanguage\":\"en-GB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2026\\\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/author\\\/irene\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/author\\\/irene\\\/#author\"},\"datePublished\":\"2026-03-11T10:11:18+01:00\",\"dateModified\":\"2026-03-11T10:22:50+01:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/\",\"name\":\"Novacos Law\",\"description\":\"Heil \\u2022 H\\u00fcbner \\u2022 Natz \\u2022 Oeben Partnerschaft mbB\",\"inLanguage\":\"en-GB\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"29. Marburger Gespr\u00e4che zum Pharmarecht (12. and 13. March 2026): Environmental protection and pharmaceutical law \/ 15 years of AMNOG \/ legal issues prior to marketing authorisation | NOVACOS","description":"Our Senior Associate Patrick Findeisen will be speaking at the Marburger Gespr\u00e4che zum Pharmarecht, taking place on March 12 and 13, 2026 in Marburg. In his presentation, Patrick will address the legal relevance of social and environmental criteria in rebate agreements in the pharmaceutical sector, with a particular focus on their growing importance to safeguard both","canonical_url":"https:\/\/www.novacos-law.com\/en\/2026\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.novacos-law.com\/en\/2026\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\/#article","name":"29. Marburger Gespr\u00e4che zum Pharmarecht (12. and 13. March 2026): Environmental protection and pharmaceutical law \/ 15 years of AMNOG \/ legal issues prior to marketing authorisation | NOVACOS","headline":"29. Marburger Gespr\u00e4che zum Pharmarecht (12. and 13. March 2026): Environmental protection and pharmaceutical law \/ 15 years of AMNOG \/ legal issues prior to marketing authorisation","author":{"@id":"https:\/\/www.novacos-law.com\/en\/author\/irene\/#author"},"publisher":{"@id":"https:\/\/www.novacos-law.com\/en\/#organization"},"datePublished":"2026-03-11T10:11:18+01:00","dateModified":"2026-03-11T10:22:50+01:00","inLanguage":"en-GB","mainEntityOfPage":{"@id":"https:\/\/www.novacos-law.com\/en\/2026\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\/#webpage"},"isPartOf":{"@id":"https:\/\/www.novacos-law.com\/en\/2026\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\/#webpage"},"articleSection":"Events"},{"@type":"BreadcrumbList","@id":"https:\/\/www.novacos-law.com\/en\/2026\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en#listItem","position":1,"name":"Home","item":"https:\/\/www.novacos-law.com\/en","nextItem":{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en\/category\/events\/#listItem","name":"Events"}},{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en\/category\/events\/#listItem","position":2,"name":"Events","item":"https:\/\/www.novacos-law.com\/en\/category\/events\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en\/2026\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\/#listItem","name":"29. Marburger Gespr\u00e4che zum Pharmarecht (12. and 13. March 2026): Environmental protection and pharmaceutical law \/ 15 years of AMNOG \/ legal issues prior to marketing authorisation"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en\/2026\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\/#listItem","position":3,"name":"29. Marburger Gespr\u00e4che zum Pharmarecht (12. and 13. March 2026): Environmental protection and pharmaceutical law \/ 15 years of AMNOG \/ legal issues prior to marketing authorisation","previousItem":{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en\/category\/events\/#listItem","name":"Events"}}]},{"@type":"Organization","@id":"https:\/\/www.novacos-law.com\/en\/#organization","name":"Novacos Law","description":"Heil \u2022 H\u00fcbner \u2022 Natz \u2022 Oeben Partnerschaft mbB","url":"https:\/\/www.novacos-law.com\/en\/"},{"@type":"Person","@id":"https:\/\/www.novacos-law.com\/en\/author\/irene\/#author","url":"https:\/\/www.novacos-law.com\/en\/author\/irene\/","name":"Irene Weigel","image":{"@type":"ImageObject","@id":"https:\/\/www.novacos-law.com\/en\/2026\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/4b6e23b267feeae9cffc7e4f81dbd2efa7e19c1035301edf6a24a7beb9ae5ac9?s=96&d=mm&r=g","width":96,"height":96,"caption":"Irene Weigel"}},{"@type":"WebPage","@id":"https:\/\/www.novacos-law.com\/en\/2026\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\/#webpage","url":"https:\/\/www.novacos-law.com\/en\/2026\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\/","name":"29. Marburger Gespr\u00e4che zum Pharmarecht (12. and 13. March 2026): Environmental protection and pharmaceutical law \/ 15 years of AMNOG \/ legal issues prior to marketing authorisation | NOVACOS","description":"Our Senior Associate Patrick Findeisen will be speaking at the Marburger Gespr\u00e4che zum Pharmarecht, taking place on March 12 and 13, 2026 in Marburg. In his presentation, Patrick will address the legal relevance of social and environmental criteria in rebate agreements in the pharmaceutical sector, with a particular focus on their growing importance to safeguard both","inLanguage":"en-GB","isPartOf":{"@id":"https:\/\/www.novacos-law.com\/en\/#website"},"breadcrumb":{"@id":"https:\/\/www.novacos-law.com\/en\/2026\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\/#breadcrumblist"},"author":{"@id":"https:\/\/www.novacos-law.com\/en\/author\/irene\/#author"},"creator":{"@id":"https:\/\/www.novacos-law.com\/en\/author\/irene\/#author"},"datePublished":"2026-03-11T10:11:18+01:00","dateModified":"2026-03-11T10:22:50+01:00"},{"@type":"WebSite","@id":"https:\/\/www.novacos-law.com\/en\/#website","url":"https:\/\/www.novacos-law.com\/en\/","name":"Novacos Law","description":"Heil \u2022 H\u00fcbner \u2022 Natz \u2022 Oeben Partnerschaft mbB","inLanguage":"en-GB","publisher":{"@id":"https:\/\/www.novacos-law.com\/en\/#organization"}}]}},"aioseo_meta_data":{"post_id":"762","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"Article","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","location":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"titles":[],"descriptions":[],"socialPosts":{"email":[],"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-03-11 09:07:10","updated":"2026-03-24 09:30:15","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.novacos-law.com\/en\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.novacos-law.com\/en\/category\/events\/\" title=\"Events\">Events<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t29. Marburger Gespr\u00e4che zum Pharmarecht (12. and 13. March 2026): Environmental protection and pharmaceutical law \/ 15 years of AMNOG \/ legal issues prior to marketing authorisation\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.novacos-law.com\/en"},{"label":"Events","link":"https:\/\/www.novacos-law.com\/en\/category\/events\/"},{"label":"29. Marburger Gespr\u00e4che zum Pharmarecht (12. and 13. March 2026): Environmental protection and pharmaceutical law \/ 15 years of AMNOG \/ legal issues prior to marketing authorisation","link":"https:\/\/www.novacos-law.com\/en\/2026\/29-marburger-gesprache-zum-pharmarecht-12-and-13-march-2026-environmental-protection-and-pharmaceutical-law-15-years-of-amnog-legal-issues-prior-to-marketing-authorisation\/"}],"_links":{"self":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/posts\/762","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/comments?post=762"}],"version-history":[{"count":0,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/posts\/762\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/media?parent=762"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/categories?post=762"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/tags?post=762"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}